If you need more lookups,
subscriptions start at $34 USD/month.
Min Lu Location
Waltham, MA, US
Min Lu Work
2025 -now Executive Director - Biology @ Eli Lilly and Company
2023 -2024 Executive Director, Head of Fibrosis @ Morphic Therapeutic (a wholly-owned subsidiary of Eli Lilly and Company since Au
2020 -2022 Senior Director, Head of Fibrosis @
2017 -2020 Director, Head of Fibrosis @
2014 -2017 Associate Principal Scientist @
2013 -2014 Staff Scientist @ Takeda California, Inc.
2012 -2013 Senior Scientist @
2010 -2012 Assistant Project Scientist @
2005 -2010 Postdoctoral Fellow @
1997 -1999 Resident Physician @ Shanghai Jing-An District Central Hospital
Min Lu Education
University of California, Riverside
PhD (Biomedical Science)
1999-2005
Shanghai Second Medical University
MD (Clinical Medicine)
1992-1997
Min Lu Skills
In Vivo
Drug Discovery
Cell Biology
In Vitro
Biochemistry
Assay Development
Life Sciences
Cell Culture
Western Blotting
Molecular & Cellular Biology
Transfection
Pharmacology
Inflammation
Metabolism
Fluorescence Microscopy
Animal Models
Physiology
Lifesciences
Protein Expression
Antibodies
Biomarkers
Immunohistochemistry
Immunofluorescence
Pathology
Diabetes and Metabolism
Cardiovascular Biology
Medicine
Viral Vectors
Peptides
Heart Failure
kidney failure
Peripheral arterial disease
Leadership
Public Speaking
Microsoft Office
Clinical Development
Molecular Biology
Molecular and Cellular Biology
Genetics
Immunoprecipitation
Min Lu Summary
Min Lu, based in Waltham, MA, US, is currently a Executive Director - Biology at Eli Lilly and Company. Min Lu brings experience from previous roles at Morphic Therapeutic (a wholly-owned subsidiary of Eli Lilly and Company since Au, Morphic Therapeutic and Merck. Min Lu holds a 1999 - 2005 PhD in Biomedical Science @ University of California, Riverside. With a robust skill set that includes In Vivo, Drug Discovery, Cell Biology, In Vitro, Biochemistry and more. Min Lu has 1 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Min Lu?
Find contact details for 700 million professionals.